---
title: "CHAIN BRIDGE I | 10-Q: FY2025 Q1 EPS: USD -0.06"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248765828.md"
datetime: "2025-07-16T10:03:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248765828.md)
  - [en](https://longbridge.com/en/news/248765828.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248765828.md)
generator: "portal-rs"
---

# CHAIN BRIDGE I | 10-Q: FY2025 Q1 EPS: USD -0.06

EPS: As of FY2025 Q1, the actual value is USD -0.06.

### Segment Revenue

-   The company did not generate any operating revenues for the three months ended March 31, 2025, as it is a blank check company focused on finding a business combination.

### Operational Metrics

-   **Net Loss**: The company reported a net loss of $363,640 for the three months ended March 31, 2025, compared to a net loss of $1,238,211 for the same period in 2024.
-   **General and Administrative Expenses**: These expenses were $191,850 for the three months ended March 31, 2025, down from $510,056 in the same period in 2024.
-   **Change in Fair Value of Derivative Liabilities**: The company recorded a gain of $187,430 from the change in fair value of derivative liabilities for the three months ended March 31, 2025, compared to a loss of $990,040 in the same period in 2024.

### Cash Flow

-   **Net Cash Used in Operating Activities**: The company used $72,033 in net cash for operating activities for the three months ended March 31, 2025, compared to $149,102 in the same period in 2024.
-   **Net Cash Used in Financing Activities**: The company used $26,328 in net cash for financing activities for the three months ended March 31, 2025, compared to $34,357,416 in the same period in 2024.

### Unique Metrics

-   **Investments Held in Trust Account**: The balance of investments held in the trust account was $5,354,147 as of March 31, 2025, compared to $5,285,060 as of December 31, 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company has until November 15, 2025, to consummate an initial business combination. If not completed by this date, the company must cease operations, redeem public shares, and liquidate.
-   **Non-Core Business**: The company terminated its business combination agreement with Phytanix Bio on April 7, 2025, and is seeking other potential business combinations.

### Related Stocks

- [CBRRF.US](https://longbridge.com/en/quote/CBRRF.US.md)

## Related News & Research

- [Why is your gold waiting on a speech?](https://longbridge.com/en/news/296733808.md)
- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Nvidia Earnings: Wall Street Expects Growth to Slow in Q2 — Dan Niles Says Hyperscalers Are Spending Like Never Before](https://longbridge.com/en/news/296822352.md)
- [There’s More to Consider, Says Investor About Sandisk Stock](https://longbridge.com/en/news/296795615.md)
- [AMD or Nvidia: Load Up on One AI Chip Stock, but Avoid the Other, Says Investor](https://longbridge.com/en/news/296792383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**